AUCTION / FDUSD

AUCTION / USDC

AUCTION / USDT

AUCTION / TRY

AUCTION / BTC

HBAR / USDC

HBAR / TRY

HBAR / USDT

HBAR / BNB

HBAR / FDUSD

BANANAS31 / USDT

BANANAS31 / USDC

KNC / USDT

KNC / BTC

DEGO / USDT

HYPER / USDT

HYPER / USDC

HYPER / TRY

SLF / TRY

RVN / BTC

VERTOZ LIMITED

SOMA TEXTILES & INDUST LT

FORGE AUTO INTERNATION L

MAXPOSURE LIMITED

VISAMAN GLOBAL SALES LTD

TARMAT LIMITED

GLENMARK PHARMACEUTICALS

SALONA COTSPIN LTD.

ENVIRO INFRA ENGINEERS L

SIGNPOST INDIA LIMITED

ROTO PUMPS LIMITED

DYNAMIC CABLES LIMITED

MIRAEAMC - INTERNET

PARSVNATH DEVELOPER LTD

DCM LTD

PENINSULA LAND LIMITED

JINDAL WORLDWIDE LTD

ZOTA HEALTH CARE LIMITED

PC JEWELLER LTD

PTL ENTERPRISES LTD

Click here to get full coverage on Rubicon Research Acquires Alkem Laboratories’ Pithampur Facility for ₹149 Crores to Boost U.S. Market Expansion - geneonline.com

Rubicon Research Acquires Alkem Laboratories’ Pithampur Facility for ₹149 Crores to Boost U.S. Market Expansion  geneonline.com

Rubicon Research Acquires Alkem Laboratories’ Pithampur Facility for ₹149 Crores to Boost U.S. Market Expansion - geneonline.com

Click here to get full coverage on What To Expect From Alkem Laboratories Ltd (NSE:ALKEM) Q3 2025 Earnings - Yahoo Finance

What To Expect From Alkem Laboratories Ltd (NSE:ALKEM) Q3 2025 Earnings  Yahoo Finance

What To Expect From Alkem Laboratories Ltd (NSE:ALKEM) Q3 2025 Earnings - Yahoo Finance

Click here to get full coverage on Alkem Laboratories shares drop 5% after Q4 results. Should you buy, sell, or hold? - The Economic Times

Alkem Laboratories shares drop 5% after Q4 results. Should you buy, sell, or hold?  The Economic Times

Alkem Laboratories shares drop 5% after Q4 results. Should you buy, sell, or hold? - The Economic Times

Click here to get full coverage on Alkem Labs Block Deal: Promoter likely to have sold 1.4% equity worth over ₹800 crore - CNBC TV18

Alkem Labs Block Deal: Promoter likely to have sold 1.4% equity worth over ₹800 crore  CNBC TV18

Alkem Labs Block Deal: Promoter likely to have sold 1.4% equity worth over ₹800 crore - CNBC TV18

Click here to get full coverage on Alkem Laboratories (NSE:ALKEM) Is Due To Pay A Dividend Of ₹8.00 - simplywall.st

Alkem Laboratories (NSE:ALKEM) Is Due To Pay A Dividend Of ₹8.00  simplywall.st

Alkem Laboratories (NSE:ALKEM) Is Due To Pay A Dividend Of ₹8.00 - simplywall.st

Click here to get full coverage on Alkem Labs Q4 Review: Jefferies Cuts Estimates, Flags Execution Risks - NDTV Profit

Alkem Labs Q4 Review: Jefferies Cuts Estimates, Flags Execution Risks  NDTV Profit

Alkem Labs Q4 Review: Jefferies Cuts Estimates, Flags Execution Risks - NDTV Profit

Click here to get full coverage on Block deal worth Rs 825 crore in Alkem Labs may see 1.42 percent equity change hands - TradingView

Block deal worth Rs 825 crore in Alkem Labs may see 1.42 percent equity change hands  TradingView

Block deal worth Rs 825 crore in Alkem Labs may see 1.42 percent equity change hands - TradingView

Click here to get full coverage on Alkem MedTech enters into a landmark agreement with Exactech for manufacturing and marketing knee and hip replacement implants in India - PR Newswire

Alkem MedTech enters into a landmark agreement with Exactech for manufacturing and marketing knee and hip replacement implants in India  PR Newswire

Alkem MedTech enters into a landmark agreement with Exactech for manufacturing and marketing knee and hip replacement implants in India - PR Newswire

Click here to get full coverage on Alkem Laboratories makes twin acquisitions - Mint

Alkem Laboratories makes twin acquisitions  Mint

Alkem Laboratories makes twin acquisitions - Mint

Click here to get full coverage on Rubicon Research Limited Completes Acquisition of Alkems Pithampur Manufacturing Unit for Rs. 149 Crores - Tribune India

Rubicon Research Limited Completes Acquisition of Alkems Pithampur Manufacturing Unit for Rs. 149 Crores  Tribune India

Rubicon Research Limited Completes Acquisition of Alkems Pithampur Manufacturing Unit for Rs. 149 Crores - Tribune India

Click here to get full coverage on Sonnet BioTherapeutics Inc. Enters into Licensing Agreement with Alkem Laboratories Limited to Develop and Commercialize SON-080 for Diabetic Peripheral Neuropathy (DPN) in India - GlobeNewswire

Sonnet BioTherapeutics Inc. Enters into Licensing Agreement with Alkem Laboratories Limited to Develop and Commercialize SON-080 for Diabetic Peripheral Neuropathy (DPN) in India  GlobeNewswire

Sonnet BioTherapeutics Inc. Enters into Licensing Agreement with Alkem Laboratories Limited to Develop and Commercialize SON-080 for Diabetic Peripheral Neuropathy (DPN) in India - GlobeNewswire

Click here to get full coverage on Alkem vs Allchem: Pharma players in a legal tussle over who owns the name - Moneycontrol

Alkem vs Allchem: Pharma players in a legal tussle over who owns the name  Moneycontrol

Alkem vs Allchem: Pharma players in a legal tussle over who owns the name - Moneycontrol

Click here to get full coverage on Intraday Trade Idea: Buy Alkem Labs Above ₹5,400, Says SEBI RA Akhilesh Jat - MSN

Intraday Trade Idea: Buy Alkem Labs Above ₹5,400, Says SEBI RA Akhilesh Jat  MSN

Intraday Trade Idea: Buy Alkem Labs Above ₹5,400, Says SEBI RA Akhilesh Jat - MSN

Click here to get full coverage on Cybersecurity incident at Alkem Labs US arm, investigation underway - Medical Dialogues

Cybersecurity incident at Alkem Labs US arm, investigation underway  Medical Dialogues

Cybersecurity incident at Alkem Labs US arm, investigation underway - Medical Dialogues

Click here to get full coverage on Pfizer Sues Alkem to Block Copies of Blockbuster Xeljanz Drug - Bloomberg Law News

Pfizer Sues Alkem to Block Copies of Blockbuster Xeljanz Drug  Bloomberg Law News

Pfizer Sues Alkem to Block Copies of Blockbuster Xeljanz Drug - Bloomberg Law News

Click here to get full coverage on Alkem Laboratories promoter Jayanti Sinha likely to sell ₹825 crore stake via block deal - CNBC TV18

Alkem Laboratories promoter Jayanti Sinha likely to sell ₹825 crore stake via block deal  CNBC TV18

Alkem Laboratories promoter Jayanti Sinha likely to sell ₹825 crore stake via block deal - CNBC TV18

Click here to get full coverage on Alkem Labs Appoints Diwakar Gupta as Independent Director - TradingView

Alkem Labs Appoints Diwakar Gupta as Independent Director  TradingView

Alkem Labs Appoints Diwakar Gupta as Independent Director - TradingView

Click here to get full coverage on Alkem Laboratories shares sink as 1.4% stake offloaded in block deal, promotor likely seller - Moneycontrol

Alkem Laboratories shares sink as 1.4% stake offloaded in block deal, promotor likely seller  Moneycontrol

Alkem Laboratories shares sink as 1.4% stake offloaded in block deal, promotor likely seller - Moneycontrol

Click here to get full coverage on Alkem Labs US arm hit by cyber fraud; financial loss under probe - CNBC TV18

Alkem Labs US arm hit by cyber fraud; financial loss under probe  CNBC TV18

Alkem Labs US arm hit by cyber fraud; financial loss under probe - CNBC TV18

Click here to get full coverage on Pfizer Sues Alkem to Block Copies of Xeljanz XR Arthritis Drug - Bloomberg Law News

Pfizer Sues Alkem to Block Copies of Xeljanz XR Arthritis Drug  Bloomberg Law News

Pfizer Sues Alkem to Block Copies of Xeljanz XR Arthritis Drug - Bloomberg Law News

Click here to get full coverage on Alkem Labs sees Rs 300 crore worth equity change hands in large deal - Moneycontrol

Alkem Labs sees Rs 300 crore worth equity change hands in large deal  Moneycontrol

Alkem Labs sees Rs 300 crore worth equity change hands in large deal - Moneycontrol

Click here to get full coverage on Alkem Laboratories eyes bigger pie of diabetes, weightloss market - Business Standard

Alkem Laboratories eyes bigger pie of diabetes, weightloss market  Business Standard

Alkem Laboratories eyes bigger pie of diabetes, weightloss market - Business Standard

Click here to get full coverage on Rs 22 Crore Gone in a Click: Pharma Giant Alkem Labs Falls Victim to Cyber Fraud - Medical Dialogues

Rs 22 Crore Gone in a Click: Pharma Giant Alkem Labs Falls Victim to Cyber Fraud  Medical Dialogues

Rs 22 Crore Gone in a Click: Pharma Giant Alkem Labs Falls Victim to Cyber Fraud - Medical Dialogues

Click here to get full coverage on Alkem Laboratories' Bioequivalence Center clears US FDA inspection without observations - CNBC TV18

Alkem Laboratories' Bioequivalence Center clears US FDA inspection without observations  CNBC TV18

Alkem Laboratories' Bioequivalence Center clears US FDA inspection without observations - CNBC TV18

Click here to get full coverage on Alkem Lab's Sarvesh Singh buys duplex on Mumbai's Carter road for Rs 174 cr - Business Standard

Alkem Lab's Sarvesh Singh buys duplex on Mumbai's Carter road for Rs 174 cr  Business Standard

Alkem Lab's Sarvesh Singh buys duplex on Mumbai's Carter road for Rs 174 cr - Business Standard

Click here to get full coverage on Alkem Labs Acquires Adroit Biomed & Bombay Ortho - Healthcare Radius

Alkem Labs Acquires Adroit Biomed & Bombay Ortho  Healthcare Radius

Alkem Labs Acquires Adroit Biomed & Bombay Ortho - Healthcare Radius

Click here to get full coverage on Alkem Laboratories Faces Bearish Technical Trends Amid Market Evaluation Revision - MarketsMojo

Alkem Laboratories Faces Bearish Technical Trends Amid Market Evaluation Revision  MarketsMojo

Alkem Laboratories Faces Bearish Technical Trends Amid Market Evaluation Revision - MarketsMojo

Click here to get full coverage on Alkem Labs promoters sell Rs 300-cr shares in block deal - The Economic Times

Alkem Labs promoters sell Rs 300-cr shares in block deal  The Economic Times

Alkem Labs promoters sell Rs 300-cr shares in block deal - The Economic Times

Click here to get full coverage on Alkem Labs duped of ₹22 cr by frauds pretending to be officials of its US arm - Hindustan Times

Alkem Labs duped of ₹22 cr by frauds pretending to be officials of its US arm  Hindustan Times

Alkem Labs duped of ₹22 cr by frauds pretending to be officials of its US arm - Hindustan Times

Click here to get full coverage on Block Deals Worth Rs 3,480 Crore On June 4 — Tata Tech, Indegene, Alkem, Aditya Birla Fashion In Focus - NDTV Profit

Block Deals Worth Rs 3,480 Crore On June 4 — Tata Tech, Indegene, Alkem, Aditya Birla Fashion In Focus  NDTV Profit

Block Deals Worth Rs 3,480 Crore On June 4 — Tata Tech, Indegene, Alkem, Aditya Birla Fashion In Focus - NDTV Profit

Click here to get full coverage on Alkem reports 7.1% YoY revenue growth in Q4 FY25 - Indian Pharma Post

Alkem reports 7.1% YoY revenue growth in Q4 FY25  Indian Pharma Post

Alkem reports 7.1% YoY revenue growth in Q4 FY25 - Indian Pharma Post

Click here to get full coverage on Alkem Labs Q3 Results: Net profit rises just 6% to ₹641 crore, total income flat; stock declines 4% - Mint

Alkem Labs Q3 Results: Net profit rises just 6% to ₹641 crore, total income flat; stock declines 4%  Mint

Alkem Labs Q3 Results: Net profit rises just 6% to ₹641 crore, total income flat; stock declines 4% - Mint

Click here to get full coverage on Alkem Promoter Jayanti Sinha To Sell 1.42% Stake Via Block Deal - NDTV Profit

Alkem Promoter Jayanti Sinha To Sell 1.42% Stake Via Block Deal  NDTV Profit

Alkem Promoter Jayanti Sinha To Sell 1.42% Stake Via Block Deal - NDTV Profit

Click here to get full coverage on Meet Seema Singh: Alkem Promoter, Owns Rs. 185 Cr Home, Entrepreneur, Mom Of 2, Bolly Celebs' Friend - BollywoodShaadis

Meet Seema Singh: Alkem Promoter, Owns Rs. 185 Cr Home, Entrepreneur, Mom Of 2, Bolly Celebs' Friend  BollywoodShaadis

Meet Seema Singh: Alkem Promoter, Owns Rs. 185 Cr Home, Entrepreneur, Mom Of 2, Bolly Celebs' Friend - BollywoodShaadis

Click here to get full coverage on Alkem Labs Promoter Sells 1.4% Stake for Rs 828 Cr - Rediff MoneyWiz

Alkem Labs Promoter Sells 1.4% Stake for Rs 828 Cr  Rediff MoneyWiz

Alkem Labs Promoter Sells 1.4% Stake for Rs 828 Cr - Rediff MoneyWiz

Click here to get full coverage on Alkem Laboratories announces strategic acquisitions of Adroit Biomed and Bombay Ortho Industries - Express Pharma

Alkem Laboratories announces strategic acquisitions of Adroit Biomed and Bombay Ortho Industries  Express Pharma

Alkem Laboratories announces strategic acquisitions of Adroit Biomed and Bombay Ortho Industries - Express Pharma

Click here to get full coverage on Alkem to buy two firms - Times of India

Alkem to buy two firms - Times of India

Click here to get full coverage on Is Alkem Lab technically bullish or bearish? - MarketsMojo

Is Alkem Lab technically bullish or bearish?  MarketsMojo

Is Alkem Lab technically bullish or bearish? - MarketsMojo

Click here to get full coverage on On Alkem Lab suit, HC says Allchem did not undertake to not enter B2C model - Informist Media

On Alkem Lab suit, HC says Allchem did not undertake to not enter B2C model  Informist Media

On Alkem Lab suit, HC says Allchem did not undertake to not enter B2C model - Informist Media

Click here to get full coverage on Alkem Labs completes acquisition of 100% stake in Adroit Biomed - Medical Dialogues

Alkem Labs completes acquisition of 100% stake in Adroit Biomed  Medical Dialogues

Alkem Labs completes acquisition of 100% stake in Adroit Biomed - Medical Dialogues

Click here to get full coverage on Diwakar Gupta to join Alkem Labs as Independent Director - Medical Dialogues

Diwakar Gupta to join Alkem Labs as Independent Director  Medical Dialogues

Diwakar Gupta to join Alkem Labs as Independent Director - Medical Dialogues

Click here to get full coverage on Stocks to Watch Today: Wipro, HDFC Bank, Alkem Labs, Aditya Birla Fashion, Indegene, Tata Technologies,... - Moneycontrol

Stocks to Watch Today: Wipro, HDFC Bank, Alkem Labs, Aditya Birla Fashion, Indegene, Tata Technologies,...  Moneycontrol

Stocks to Watch Today: Wipro, HDFC Bank, Alkem Labs, Aditya Birla Fashion, Indegene, Tata Technologies,... - Moneycontrol

Click here to get full coverage on Exactech partners with Alkem MedTech for joint implants in India - Medical Device Network

Exactech partners with Alkem MedTech for joint implants in India  Medical Device Network

Exactech partners with Alkem MedTech for joint implants in India - Medical Device Network

Click here to get full coverage on Alkem Laboratories Unveils MediSamvad: A Digital Knowledge Platform for Healthcare Professionals - eHealth Magazine

Alkem Laboratories Unveils MediSamvad: A Digital Knowledge Platform for Healthcare Professionals  eHealth Magazine

Alkem Laboratories Unveils MediSamvad: A Digital Knowledge Platform for Healthcare Professionals - eHealth Magazine

Click here to get full coverage on Alkem Laboratories Ltd up for third straight session - Business Standard

Alkem Laboratories Ltd up for third straight session  Business Standard

Alkem Laboratories Ltd up for third straight session - Business Standard

Click here to get full coverage on Rubicon completes Rs 149 crore deal for Alkem’s Pithampur plant - Healthcare Radius

Rubicon completes Rs 149 crore deal for Alkem’s Pithampur plant  Healthcare Radius

Rubicon completes Rs 149 crore deal for Alkem’s Pithampur plant - Healthcare Radius

Click here to get full coverage on Alkem Labs buying two firms to foray into medical devices, grow dermatology biz - VCCircle

Alkem Labs buying two firms to foray into medical devices, grow dermatology biz  VCCircle

Alkem Labs buying two firms to foray into medical devices, grow dermatology biz - VCCircle

Click here to get full coverage on Rubicon Research completes acquisition of Alkem’s Pithampur manufacturing unit for Rs149 Cr - BioSpectrum India

Rubicon Research completes acquisition of Alkem’s Pithampur manufacturing unit for Rs149 Cr  BioSpectrum India

Rubicon Research completes acquisition of Alkem’s Pithampur manufacturing unit for Rs149 Cr - BioSpectrum India

Click here to get full coverage on Alkem Labs shares drop 4% after Q4 EBITDA margin contracts to 12.4%: Should you buy, sell or hold? - Moneycontrol

Alkem Labs shares drop 4% after Q4 EBITDA margin contracts to 12.4%: Should you buy, sell or hold?  Moneycontrol

Alkem Labs shares drop 4% after Q4 EBITDA margin contracts to 12.4%: Should you buy, sell or hold? - Moneycontrol

Click here to get full coverage on Sonnet Partners Alkem To Develop And Market SON-080 For Diabetic Peripheral Neuropathy In India - Nasdaq

Sonnet Partners Alkem To Develop And Market SON-080 For Diabetic Peripheral Neuropathy In India  Nasdaq

Sonnet Partners Alkem To Develop And Market SON-080 For Diabetic Peripheral Neuropathy In India - Nasdaq

Click here to get full coverage on Alkem Labs Senior Management Personnel Adil Billimoria retires - Medical Dialogues

Alkem Labs Senior Management Personnel Adil Billimoria retires  Medical Dialogues

Alkem Labs Senior Management Personnel Adil Billimoria retires - Medical Dialogues

Click here to get full coverage on Alkem Labs announces acquisitions in skincare and medical devices segments - BusinessLine

Alkem Labs announces acquisitions in skincare and medical devices segments  BusinessLine

Alkem Labs announces acquisitions in skincare and medical devices segments - BusinessLine

Click here to get full coverage on Alkem reports cyber security incident at Enzene’s US subsidiary - BusinessLine

Alkem reports cyber security incident at Enzene’s US subsidiary  BusinessLine

Alkem reports cyber security incident at Enzene’s US subsidiary - BusinessLine

Click here to get full coverage on Alkem launches generic empagliflozin and its combinations in India under ‘Empanorm’ - Indian Pharma Post

Alkem launches generic empagliflozin and its combinations in India under ‘Empanorm’  Indian Pharma Post

Alkem Laboratories Limited (ALKEM)

Price Chart

Key Statistics

Technicals

About ALKEM

Latest News

Rubicon Research Acquires Alkem Laboratories’ Pithampur Facility for ₹149 Crores to Boost U.S. Market Expansion - geneonline.com

What To Expect From Alkem Laboratories Ltd (NSE:ALKEM) Q3 2025 Earnings - Yahoo Finance

Alkem Laboratories shares drop 5% after Q4 results. Should you buy, sell, or hold? - The Economic Times

Advanced Charts

Top Gainers

Top Losers